|
|
||||||||
The Annals of Thoracic Surgery, Vol 58, 1574-1578, Copyright © 1994 by The Society of Thoracic Surgeons
CD Wright, DJ Mathisen, JC Wain, HC Grillo, AD Hilgenberg, AC Moncure, RW Carey, NC Choi, M Daly and DL Logan
Between 1980 and 1988, 91 patients with adenocarcinoma of the esophagus
were treated by surgical resection and selective postoperative therapy.
Operative mortality was 2%. Pathologic stage was I in 4, II in 26, and III
in 61. Actuarial 2- and 5-year survival was 24% and 8%. From 1987 to 1989,
16 patients with adenocarcinoma of the esophagus were treated with two
cycles of 5-fluorouracil and cisplatin followed by surgical resection.
There was 1 complete response (6%), 5 partial responses (31%), and 10 with
no response (63%). Twelve patients had resection. Pathologic stage was I in
1, II in 4, and III in 8. There was one chemotherapy-related death and one
surgical death. Actuarial 4-year survival is 42%. From 1990 to 1993, 22
patients with adenocarcinoma of the esophagus were treated with two cycles
of etoposide, doxorubicin, and cisplatin followed by surgical resection.
There was 1 complete response (5%), 11 partial responses (50%), and 10 with
no response (45%). Eighteen patients had resection. Pathologic stage was 0
in 1, II in 8, and III in 9. There were no treatment-related deaths. The
actuarial 2-year survival is 58%. Conclusions are necessarily limited
because the patients were not treated in a randomized fashion. These
preliminary results with preoperative chemotherapy appear improved (p =
0.04 and p = 0.004, respectively) as compared with results from 1980 to
1988 without preoperative chemotherapy.
ARTICLES
Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction
General Thoracic Surgical Unit, Massachusetts General Hospital, Boston 02114.
This article has been cited by other articles:
![]() |
P. A.M. Heeren, P. L. Jager, F. Bongaerts, H. van Dullemen, W. Sluiter, and J. Th.M. Plukker Detection of Distant Metastases in Esophageal Cancer with 18F-FDG PET J. Nucl. Med., June 1, 2004; 45(6): 980 - 987. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Igaki, H. Kato, Y. Tachimori, H. Sato, H. Daiko, and Y. Nakanishi Prognostic evaluation for squamous cell carcinomas of the lower thoracic esophagus treated with three-field lymph node dissection Eur. J. Cardiothorac. Surg., June 1, 2001; 19(6): 887 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. van de Ven, P. De Leyn, W. Coosemans, D. Van Raemdonck, and T. Lerut Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Wright, J. C. Wain, T. J. Lynch, N. C. Choi, M. L. Grossbard, R. W. Carey, A. C. Moncure, H. C. Grillo, and D. J. Mathisen INDUCTION THERAPY FOR ESOPHAGEAL CANCER WITH PACLITAXEL AND HYPERFRACTIONATED RADIOTHERAPY: A PHASE I AND II STUDY J. Thorac. Cardiovasc. Surg., November 1, 1997; 114(5): 811 - 816. [Abstract] [Full Text] |
||||
![]() |
W. H. Steup, P. De Leyn, G. Deneffe, D. Van Raemdonck, W. Coosemans, and T. Lerut TUMORS OF THE ESOPHAGOGASTRIC JUNCTIONLong-term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification J. Thorac. Cardiovasc. Surg., January 1, 1996; 111(1): 85 - 95. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |